SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001968582-23-000750
Filing Date
2023-12-08
Accepted
2023-12-08 17:36:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2845
  Complete submission text file 0001968582-23-000750.txt   4220
Mailing Address C/O ORBIMED ADVISORS 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address
Khuong Chau Quang (Reporting) CIK: 0001609405 (see all company filings)

Type: 144

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Subject) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39344 | Film No.: 231476488
SIC: 2836 Biological Products, (No Diagnostic Substances)